Our team at Eikon Therapeutics is making waves in drug discovery by leveraging cutting-edge AI technologies. Eikon Associate Director Adi Hanuka, PhD, recently presented how our advanced AI models are overcoming challenges in predicting drug absorption. By integrating public and proprietary data, our models are significantly improving prediction accuracy, leading to faster and more effective drug development. Excited about the future? We are too! Stay tuned for more groundbreaking advancements from our talented team. #TeamEikon #AI #DrugDiscovery #BiotechInnovation
In drug development, accurately predicting drug properties is crucial. But how do you achieve this with limited proprietary data? At Eikon Therapeutics we found a solution that worked well for us. 🚀💊 In this article, we describe our methods to improve our AI models for predicting drug properties and their impact on our drug discovery process.